These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
629 related articles for article (PubMed ID: 11346466)
41. Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA-Rock and Src-FAK signalling in colon cancer cells. Leve F; Marcondes TG; Bastos LG; Rabello SV; Tanaka MN; Morgado-Díaz JA Eur J Pharmacol; 2011 Dec; 671(1-3):7-17. PubMed ID: 21968138 [TBL] [Abstract][Full Text] [Related]
42. E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells. Hakuma N; Kinoshita I; Shimizu Y; Yamazaki K; Yoshida K; Nishimura M; Dosaka-Akita H Cancer Res; 2005 Dec; 65(23):10776-82. PubMed ID: 16322223 [TBL] [Abstract][Full Text] [Related]
43. Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways. Cheng HL; Lin CW; Yang JS; Hsieh MJ; Yang SF; Lu KH Oncotarget; 2016 Mar; 7(9):9742-58. PubMed ID: 26848867 [TBL] [Abstract][Full Text] [Related]
44. Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Amano M; Chihara K; Kimura K; Fukata Y; Nakamura N; Matsuura Y; Kaibuchi K Science; 1997 Feb; 275(5304):1308-11. PubMed ID: 9036856 [TBL] [Abstract][Full Text] [Related]
45. Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion. Fromigué O; Hamidouche Z; Marie PJ J Biol Chem; 2008 Nov; 283(45):30549-56. PubMed ID: 18757369 [TBL] [Abstract][Full Text] [Related]
46. Role of RhoA and Rho kinase in lysophosphatidic acid-induced endothelial barrier dysfunction. van Nieuw Amerongen GP; Vermeer MA; van Hinsbergh VW Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):E127-33. PubMed ID: 11116077 [TBL] [Abstract][Full Text] [Related]
47. Interaction between mDia1 and ROCK in Rho-induced migration and adhesion of human dental pulp cells. Cheng L; Xu J; Qian YY; Pan HY; Yang H; Shao MY; Cheng R; Hu T Int Endod J; 2017 Jan; 50(1):15-23. PubMed ID: 26609804 [TBL] [Abstract][Full Text] [Related]
48. Small guanosine triphospatase RhoA and Rho-associated kinase as regulators of trophoblast migration. Shiokawa S; Iwashita M; Akimoto Y; Nagamatsu S; Sakai K; Hanashi H; Kabir-Salmani M; Nakamura Y; Uehata M; Yoshimura Y J Clin Endocrinol Metab; 2002 Dec; 87(12):5808-16. PubMed ID: 12466390 [TBL] [Abstract][Full Text] [Related]
49. Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway. Choi YA; Lim HK; Kim JR; Lee CH; Kim YJ; Kang SS; Baek SH J Biol Chem; 2004 Aug; 279(35):36579-85. PubMed ID: 15220345 [TBL] [Abstract][Full Text] [Related]
50. ANG II and LPA induce Pyk2 tyrosine phosphorylation in intestinal epithelial cells: role of Ca2+, PKC, and Rho kinase. Wu SS; Chiu T; Rozengurt E Am J Physiol Cell Physiol; 2002 Jun; 282(6):C1432-44. PubMed ID: 11997258 [TBL] [Abstract][Full Text] [Related]
51. Protein kinase A inhibits lysophosphatidic acid-induced migration of airway smooth muscle cells. Hirakawa M; Karashima Y; Watanabe M; Kimura C; Ito Y; Oike M J Pharmacol Exp Ther; 2007 Jun; 321(3):1102-8. PubMed ID: 17347321 [TBL] [Abstract][Full Text] [Related]
52. Role of lysophosphatidic acid and rho in glioma cell motility. Manning TJ; Parker JC; Sontheimer H Cell Motil Cytoskeleton; 2000 Mar; 45(3):185-99. PubMed ID: 10706774 [TBL] [Abstract][Full Text] [Related]
53. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo. Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294 [TBL] [Abstract][Full Text] [Related]
54. FAK-mediated src phosphorylation of endophilin A2 inhibits endocytosis of MT1-MMP and promotes ECM degradation. Wu X; Gan B; Yoo Y; Guan JL Dev Cell; 2005 Aug; 9(2):185-96. PubMed ID: 16054026 [TBL] [Abstract][Full Text] [Related]
56. Inhibition of matrix metalloproteinase-14 in osteosarcoma cells by clodronate. Heikkilä P; Teronen O; Hirn MY; Sorsa T; Tervahartiala T; Salo T; Konttinen YT; Halttunen T; Moilanen M; Hanemaaijer R; Laitinen M J Surg Res; 2003 May; 111(1):45-52. PubMed ID: 12842447 [TBL] [Abstract][Full Text] [Related]
57. Sequential activation of RhoA and FAK/paxillin leads to ATP release and actin reorganization in human endothelium. Hirakawa M; Oike M; Karashima Y; Ito Y J Physiol; 2004 Jul; 558(Pt 2):479-88. PubMed ID: 15155793 [TBL] [Abstract][Full Text] [Related]
58. Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway. Zhu B; Shi S; Ma YG; Fan F; Yao ZZ Hepatogastroenterology; 2012 May; 59(115):785-9. PubMed ID: 22020916 [TBL] [Abstract][Full Text] [Related]
60. Deguelin inhibits the migration and invasion of U-2 OS human osteosarcoma cells via the inhibition of matrix metalloproteinase-2/-9 in vitro. Shang HS; Chang JB; Lin JH; Lin JP; Hsu SC; Liu CM; Liu JY; Wu PP; Lu HF; Au MK; Chung JG Molecules; 2014 Oct; 19(10):16588-608. PubMed ID: 25322282 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]